Skip to main content

Table 1 The results for GO analysis in stable CAD patients compared to healthy subjects

From: KLRD1, FOSL2 and LILRB3 as potential biomarkers for plaques progression in acute myocardial infarction and stable coronary artery disease

Gene set

Description

Size

Expect

Ratio

P value

FDR

GO:1901652

Response to peptide

487

3.6508

4.3826

6.73E−07

0.00028587

GO:0002237

Response to molecule of bacterial origin

330

2.4738

5.255

0.000001115

0.00031591

GO:0060326

Cell chemotaxis

289

2.1665

5.0774

0.000010863

0.0018467

GO:0042326

Negative regulation of phosphorylation

423

3.171

4.0997

0.000016617

0.0020178

GO:0048285

Organelle fission

459

3.4409

3.7781

0.00003896

0.0041396

GO:0002764

Immune response-regulating signaling pathway

485

3.6358

3.5756

0.000068438

0.0054448

GO:0044772

Mitotic cell cycle phase transition

487

3.6508

3.5609

0.000071351

0.0054448

GO:0042110

T cell activation

452

3.3884

3.5415

0.00014479

0.007344

GO:0051090

Regulation of DNA-binding Transcription factor activity

404

3.0286

3.6321

0.00022327

0.0094891

GO:0097191

Extrinsic apoptotic signaling pathway

220

1.6492

4.8508

0.00024866

0.0096073

  1. GO, gene-ontology; CAD, coronary artery disease; FDR, false discovery rate